GlassScriptExceed Biplanar Expandable Interbody System
Payments companies reported to CMS as associated with Exceed Biplanar Expandable Interbody System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Exceed Biplanar Expandable Interbody System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Exceed Biplanar Expandable Interbody System
These are the largest totals companies reported as associated with Exceed Biplanar Expandable Interbody System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Christopher Wagener | Bethlehem, PA | Orthopaedic Surgery | $18,176.06 |
| Justin Iorio | Syracuse, NY | Orthopaedic Surgery of The Spine | $15,327.00 |
| Pedro Ramirez | Lake Mary, FL | Neurological Surgery | $14,872.00 |
| Dejan Slavnic | Novi, MI | Neurological Surgery | $13,439.81 |
| Paul Celestre | Louisville, KY | Orthopaedic Surgery of The Spine | $7,750.00 |
| Mokbel Chedid | Detroit, MI | Neurological Surgery | $7,750.00 |
| Christopher Holland | Concord, NC | Neurological Surgery | $4,500.00 |
| Joseph Hobbs | Augusta, GA | Family Medicine | $3,500.00 |
| Paul Krafft | Daytona Beach, FL | Neurological Surgery | $3,500.00 |
| Richard Boyer | Knoxville, TN | Neurological Surgery | $2,750.00 |
Share this page
The CSV has this whole record: yearly totals, every maker, the specialty mix, and the clinicians with the largest associated totals.
Prescribed Exceed Biplanar Expandable Interbody System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.